Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
Read this issue’s cover story titled “Specialists navigate changing, challenging landscape of geographic atrophy management.” ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, five-year efficacy, safety and durability data from the Phase ...
Researchers think they know why eye injections for “wet” AMD sometimes fail The eye injections actually increase a protein linked to new blood vessel growth An experimental drug reduced levels of ...
Age-Related Macular Degeneration (AMD) is the biggest cause of sight loss in the UK, affecting around 700,000 people. As February is AMD Awareness Month, Optegra Eye Clinic West London is spotlighting ...
Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr Dao Nguyen examines a vial of lutein formulation developed for potential use in eyedrop treatments. (CREDIT: Will Wright, RMIT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results